Hao Cui
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Immune cells in cancer
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 2
-
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Yuyue Zhao (6 shared papers)Guang‐Tao Yu (6 shared papers)Guowang Cheng (2 shared papers)Lushan Xiao (15 shared papers)Lang Rao (1 shared paper)Limin Ma (1 shared paper)Zhou Lan (1 shared paper)Li Liu (11 shared papers)
In The Last Decade
Hao Cui
28 papers receiving 304 citations
Peers
Comparison fields: 5 of 75
- Hepatology 33
- Immunology 72
- Oncology 81
- Biomaterials 28
- Biomedical Engineering 83
Countries citing papers authored by Hao Cui
This map shows the geographic impact of Hao Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Cui more than expected).
Fields of papers citing papers by Hao Cui
This network shows the impact of papers produced by Hao Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Cui. The network helps show where Hao Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 99 | |
| 2 | 2022 | 24 | |
| 3 | 2022 | 19 | |
| 4 | 2022 | 17 | |
| 5 | 2024 | 16 | |
| 6 | 2024 | 13 | |
| 7 | 2023 | 12 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2022 | 10 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2024 | 7 | |
| 14 | 2022 | 7 | |
| 15 | 2023 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2022 | 4 |
About Hao Cui
Hao Cui is a scholar working on Oncology, Epidemiology, Immunology, Molecular Biology and Hepatology, having authored 28 papers that have together received 305 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immune cells in cancer (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Ferroptosis and cancer prognosis (3 papers), Nanoplatforms for cancer theranostics (2 papers), CAR-T cell therapy research (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Hepatology (33 citations), Immunology (72 citations), Oncology (81 citations), Biomaterials (28 citations) and Biomedical Engineering (83 citations). Hao Cui has collaborated with scholars based in China, Germany and Singapore. Frequent co-authors include Yuyue Zhao, Guang‐Tao Yu, Guowang Cheng, Lushan Xiao, Lang Rao, Limin Ma, Zhou Lan, Li Liu, Tongkai Chen and Qian‐Fang Meng. Their work appears in journals such as Cancer Immunology Immunotherapy, Advanced Science, Oral Diseases, Journal of Clinical Medicine and Annals of Palliative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.